Showing results (1631-1640 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 23, 2020
Effective upfront treatment with low-dose ibrutinib for a patient with B cell prolymphocytic leukemiaSatoko Oka, Kazuo Ono, Masaharu NohgawaInvestigational New Drugs|September 20, 2014
Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) studyJoal D Beane, Kayla F Griffin, Elliot B Levy, et al.Investigational New Drugs|May 6, 2016
Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing miceBence Kapuvári, Rózsa Hegedüs, Ákos Schulcz, et al.Investigational New Drugs|September 5, 2020
The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphomaChie Ishikawa, Naoki MoriInvestigational New Drugs|November 7, 2020
Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320)Sakiko Otani, Jiichiro Sasaki, Yoshiro Nakahara, et al.Investigational New Drugs|September 19, 2020
Relevance of the combination of external beam radiotherapy with the hypoxia-activated prodrug ICF05016 in an experimental model of extraskeletal myxoid chondrosarcomaElise Maubert, Valérie Weber, Aurélien Voissière, et al.Investigational New Drugs|September 21, 2020
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinomaHiroaki Kodama, Kazushige Wakuda, Michitoshi Yabe, et al.Investigational New Drugs|June 10, 2021
Phase 1a study of the CDK4/6 inhibitor, FCN-437c, in Chinese patients with HR + /HER2- advanced breast cancerJian Zhang, Xiaojia Wang, Xian Wang, et al.Investigational New Drugs|April 1, 1988
Use of human neuroblastoma continuous cell lines for in vitro drug sensitivity screeningB T Hill, R D Whelan, L K HoskingInvestigational New Drugs|April 1, 1988
Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU)B Hartley-Asp, P I Christensson, K Gunnarsson, et al.Pageof 372